|
Volumn 89, Issue 3, 2000, Pages 242-250
|
Management of malignant melanoma
|
Author keywords
Malignant melanoma; Management
|
Indexed keywords
BLOOD ANALYSIS;
CANCER EPIDEMIOLOGY;
CONTRACEPTION;
DIAGNOSTIC PROCEDURE;
EXCISION;
FOLLOW UP;
HORMONE ACTION;
HUMAN;
LYMPH NODE METASTASIS;
MELANOMA;
OCCULT CANCER;
PRACTICE GUIDELINE;
PREGNANCY;
RADIOLOGICAL PARAMETERS;
REVIEW;
RISK FACTOR;
SKIN DEFECT;
WESTERN EUROPE;
ADULT;
ANIMALS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOPSY;
CASE-CONTROL STUDIES;
DACARBAZINE;
DIAGNOSIS, DIFFERENTIAL;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LIFE EXPECTANCY;
LYMPH NODE EXCISION;
LYMPHATIC METASTASIS;
MALE;
MELANOMA;
MIDDLE AGED;
NEOPLASM METASTASIS;
NEOPLASM RECURRENCE, LOCAL;
PRACTICE GUIDELINES;
PREGNANCY;
PREGNANCY COMPLICATIONS, NEOPLASTIC;
PROGNOSIS;
RISK FACTORS;
SKIN;
SKIN NEOPLASMS;
SUNSCREENING AGENTS;
SURVIVAL ANALYSIS;
TIME FACTORS;
|
EID: 30344442498
PISSN: 03559521
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (10)
|
References (25)
|